We are live on ! Find out more
GALT icon

Galectin Therapeutics

60 hedge funds and large institutions have $17.4M invested in Galectin Therapeutics in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

215% more call options, than puts

Call options by funds: $63K | Put options by funds: $20K

66% more capital invested

Capital invested by funds: $10.5M → $17.4M (+$6.91M)

50% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 8

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

3% more ownership

Funds ownership: 12.22%15.22% (+3%)

0% more funds holding

Funds holding: 6060 (0)

Holders
60
Holders Change
Holders Change %
0%
% of All Funds
0.95%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
12
Reduced
8
Closed
4
Calls
$63K
Puts
$20K
Net Calls
+$43K
Net Calls Change
-$31K